Results 111 to 120 of about 3,343,278 (165)

Altered wakeful theta activity characterizes levodopa-induced dyskinesia in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Fiorillo L, Lombardi G, La Porta N, Arnaud L, Veneruso M, Castelnovo A, Bertaina I, Staedler C, Kaelin-Lang A, Galati S.   +9 more
europepmc   +1 more source

Cell- and state-specific plasticity of striatal glutamatergic synapses is critical to the expression of levodopa-induced dyskinesia. [PDF]

Neuron
Shen W, Zhai S, Francardo V, Cui Q, Sun L, Xie Z, Tkatch T, Corredor VE, Lein ES, Ting JT, Cenci MA, Surmeier DJ.   +11 more
europepmc   +1 more source

Serum zinc deficiency is a potential risk factor for the occurrence of levodopa-induced dyskinesia in drug-naïve Parkinson's disease. [PDF]

Front Aging Neurosci, 2023
Kim JE, Lee HS, Jang W.
europepmc   +1 more source

ATG14-Mediated SNARE Complex Activation Promotes ΔFosB Degradation to Ameliorate Levodopa-Induced Dyskinesia. [PDF]

J Neurochem
Wu Y, Liu K, Zhang Z, Ma Z, Tang Z, Chang A, Ouyang H, Zhai H, Cao X, Xu Y.   +9 more
europepmc   +1 more source

Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohort. [PDF]

J Parkinsons Dis
Chaparro-Solano HM, Teixeira-Dos-Santos D, Waldo E, Leal TP, Inca-Martinez M, Alcauter S, Medina-Rivera A, Ruiz-Contreras AE, Cornejo-Olivas M, Mejia-Rojas K, Armas C, Chana-Cuevas P, Rojas N, Orozco JL, Ospina BM, Aguillon D, Buritica O, Masmela SM, Tumas V, Schuh AF, Rieder CR, Santos-Lobato BL, Duarte JS, Peña Martínez SL, Rodríguez-Violante M, Hernández-Medrano AJ, Gatto EM, Da Prat De Magalhaes GA, Arboleda G, Kauffman MA, Rodriguez-Quiroga SA, Vinuela A, Espinal Martinez AO, Braga-Neto P, Camargos S, Fernandez-Toledo E, Avila CL, Cardoso FE, Olguin P, Borges V, Müller MV, Merello M, Rosso A, Martinez-Ramirez D, Adamec DS, Tela MS, Letro GH, Nicaretta DH, Mata IF, Latin American Research consortium on the Genetics of Parkinson's Disease (LARGE-PD).   +49 more
europepmc   +1 more source

Amphiregulin blockade decreases the levodopa-induced dyskinesia in a 6-hydroxydopamine Parkinson's disease mouse model. [PDF]

CNS Neurosci Ther, 2023
Kambey PA, Liu WY, Wu J, Tang C, Buberwa W, Saro A, Nyalali AMK, Gao D.   +7 more
europepmc   +1 more source

Levodopa-induced dyskinesia: interplay between the N-methyl-D-aspartic acid receptor and neuroinflammation. [PDF]

Front Immunol, 2023
Zhang F, Liu M, Tuo J, Zhang L, Zhang J, Yu C, Xu Z.   +6 more
europepmc   +1 more source

Nardosinone improves levodopa-induced dyskinesia in Parkinsonian rats through the microbiota-gut-brain axis. [PDF]

Sci Rep
Xue J, Liu M, Cao Y, Hao Z, Wang Y, Wang Y, Lu Y, Fan W, Zhang G, Shi J.   +9 more
europepmc   +1 more source

Altered dynamic functional network connectivity in levodopa-induced dyskinesia of Parkinson's disease. [PDF]

CNS Neurosci Ther, 2023
Si Q, Gan C, Zhang H, Cao X, Sun H, Wang M, Wang L, Yuan Y, Zhang K.   +8 more
europepmc   +1 more source

Cortical Intra-Layer Hypersynchronization in Levodopa-Induced Dyskinesia Mouse Model. [PDF]

Brain Behav
Khateb M, Aeed F, Achvat S, Ron S, Schiller Y.   +4 more
europepmc   +1 more source